The role of adenosine in preconditioning

Pharmacology and Therapeutics

Volumn 87, Issue 2-3, 2000, Pages 141-149

  De Jong, J W ^a   De Jonge, R ^a   Keijzer, E ^a   Bradamante, S ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b CNR   (Italy)

Author keywords

Adenosine receptor; Carbohydrate; Cardiovascular disease; Ischemic preconditioning; K(ATP) channel; Protein kinase C

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 5' NUCLEOTIDASE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; ANGIOTENSIN RECEPTOR; BRADYKININ RECEPTOR; CARBOHYDRATE; CATECHOLAMINE RECEPTOR; CHOLINERGIC RECEPTOR; ENDOTHELIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OPIATE RECEPTOR; PHOSPHOTRANSFERASE; PROTEIN KINASE; PROTEIN KINASE C; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TYROSINE;

CARBOHYDRATE METABOLISM; CONFERENCE PAPER; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; POTASSIUM CHANNEL; PRIORITY JOURNAL; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VASODILATATION;

5'-NUCLEOTIDASE; ADENOSINE; GTP-BINDING PROTEINS; HUMAN; ION CHANNELS; ISCHEMIC PRECONDITIONING; MYOCARDIUM; PROTEIN KINASE C; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0033797393     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00044-9     Document Type: Conference Paper

References (76)

1. Abete P., Ferrara N., Cioppa A., Ferrara P., Bianco S., Calabrese C., Cacciatore F., Longobardi G., Rengo F. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol. 27:1996;1777-1786.
2. Abete P., Ferrara N., Cacciatore F., Madrid A., Bianco S., Calabrese C., Napoli C., Scognamiglio P., Bollella O., Cioppa A., Longobardi G., Rengo F. Angina-induced protection against myocardial infarction in adult and elderly patients. a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol. 30:1997;947-954.
3. Anonymous Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology. 83:1995;658-673.
4. Asimakis G.K. Myocardial glycogen depletion cannot explain the cardioprotective effects of ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 28:1996;563-570.
5. Baines C.P., Wang L., Cohen M.V., Downey J.M. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol. 30:1998;383-392.
6. Barbosa V., Sievers R.E., Zaugg C.E., Wolfe C.L. Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts. Am Heart J. 131:1996;224-230.
7. Bouchard J.-F., Lamontagne D. Protection afforded by preconditioning to the diabetic heart against ischaemic injury. Cardiovasc Res. 37:1998;82-90.
8. Bradamante S., de Jonge R., de Jong J.W. Adenosine agonist mimics ischemic preconditioning. J Mol Cell Cardiol. 29:1997;A67.
9. 3 receptors in protection of isolated human atrial muscle against simulated ischaemia. Cardiovasc Res. 36:1997;52-59.
10. Cave A.C., Silverman A.S., Apstein C.S. Ischemic preconditioning does not protect against contractile dysfunction in the presence of residual flow. studies in the isolated, blood-perfused rat heart Circulation. 96:1997;3087-3093.
11. Cleveland J.C. Jr., Meldrum D.R., Cain B.S., Banerjee A., Harken A.H. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation. 96:1997;29-32.
12. de Jong J.W., de Jonge R., Marchesani A., Janssen M., Bradamante S. Controversies in preconditioning. Cardiovasc Drugs Ther. 10:1996;767-773.
13. de Jonge, R. (1999). Adenosine, carbohydrates and ischemic preconditioning. Academic Thesis, Erasmus University, Rotterdam.
14. 1 receptor Cardiovasc Res. 43:1999;909-918.
15. de Jonge R., Macleod D.C., Suryapranata H., van Es G.A., Friedman J., Serruys P.W., de Jong J.W. Effect of acadesine on myocardial ischaemia in patients with coronary artery disease. Eur J Pharmacol. 337:1997;41-44.
16. de Jonge R., Bradamante S., Speleman L., de Jong J.W. Carbohydrates and purines in underperfused hearts, protected by ischemic preconditioning. J Mol Cell Cardiol. 30:1998;699-708.
17. de Jonge R., de Jong J.W., Giacometti D., Bradamante S. Adenosine-mediated cardioprotection and glycogenolysis. FASEB J. 13:1999;A1080. a.
18. 3 receptor activation. In Abstract Book of the Keystone Symposium on Apoptosis and Programmed Cell Death, Breckenridge, CO, p. 96.
19. 3 receptor. FASEB J. 12:1998;1785-1792.
20. Downey J.M., Cohen M.V. Preconditioning. what it is and how it works Dialogues Cardiovasc Med. 2:1997;179-196.
21. 1 receptor function in the rat heart. J Mol Cell Cardiol. 29:1997;593-602.
22. Gho B.C., Schoemaker R.G., van den Doel M.A., Duncker D.J., Verdouw P.D. Myocardial protection by brief ischemia in noncardiac tissue. Circulation. 94:1996;2193-2200.
23. Goto M., Liu Y., Yang X.-M., Ardell J.L., Cohen M.V., Downey J.M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 77:1995;611-621.
24. Gottlieb R.A., Gruol D.L., Zhu J.Y., Engler R.L. Preconditioning rabbit cardiomyocytes. role of pH, vacuolar proton ATPase, and apoptosis J Clin Invest. 97:1996;2391-2398.
25. Gross G.J. Recombinant cardiac ATP-sensitive potassium channels and cardioprotection. Circulation. 98:1998;1479-1480.
26. Harrison G.J., Willis R.J., Headrick J.P. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res. 40:1998;74-87.
27. Headrick J.P. Ischemic preconditioning. bioenergetic and metabolic changes and the role of endogenous adenosine J Mol Cell Cardiol. 28:1996;1227-1240.
28. Headrick J.P., Matherne G.P., Berr S.S., Berne R.M. Effects of graded perfusion and isovolumic work on epicardial and venous adenosine and cytosolic metabolism. J Mol Cell Cardiol. 23:1991;309-324.
29. 1 adenosine receptor overexpression markedly improves myocardial energy state during ischemia-reperfusion. J Mol Cell Cardiol. 30:1998;1059-1064.
30. 3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. J Mol Cell Cardiol. 30:1998;579-585.
31. Ishida T., Yarimizu K., Gute D.C., Korthuis R.J. Mechanisms of ischemic preconditioning. Shock. 8:1997;86-94.
32. King L.M., Opie L.H. Does preconditioning act by glycogen depletion in the isolated rat heart? J Mol Cell Cardiol. 28:1996;2305-2321.
33. King L.M., Boucher F., Opie L.H. Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium. J Mol Cell Cardiol. 27:1995;701-720.
34. Kitakaze M., Hori M., Takashima S., Sato H., Inoue M., Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation. 87:1993;208-215.
35. Lasley R.D., Konyn P.J., Hegge J.O., Mentzer R.M. Jr. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol. 269:1995;H1460-H1466.
36. Lee H.T., LaFaro R.J., Reed G.E. Pretreatment of human myocardium with adenosine during open heart surgery. J Cardiovasc Surg. 10:1995;665-676.
37. Leesar M.A., Stoddard M., Ahmed M., Broadbent J., Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 95:1997;2500-2507.
38. ATP channel. Am J Physiol. 271:1996;H1769-H1777.
39. 1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356.
40. Liu Y., Ytrehus K., Downey J.M. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol. 26:1994;661-668.
41. 1 adenosine receptors of intact rat ventricular myocytes. Circ Res. 63:1988;613-620.
42. Maulik N., Watanabe M., Zu Y.-L., Huang C.-K., Cordis G.A., Schley J.A., Das D.K. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 396:1996;233-237.
43. Menasché P., Jamieson W.R., Flameng W., Davies M.K. Acadesine. a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group J Thorac Cardiovasc Surg. 110:1995;1096-1106.
44. Mentzer R.M. Jr., Rahko P.S., Molina-Viamonte V., Canver C.C., Chopra P.S., Love R.B., Cook T.D., Hegge J.O., Lasley R.D. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol. 79:1997;38-43.
45. Mitchell M.B., Meng X., Ao L., Brown J.M., Harken A.H., Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 76:1995;73-81.
46. Miura T., Iimura O. Infarct size limitation by preconditioning. its phenomenological features and the key role of adenosine Cardiovasc Res. 27:1993;36-42.
47. Mullane K., Bullough D. Harnessing an endogenous cardioprotective mechanism. cellular sources and sites of action of adenosine J Mol Cell Cardiol. 27:1995;1041-1054.
48. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia. a delay of lethal cell injury in ischemic myocardium Circulation. 74:1986;1124-1136.
49. Murry C.E., Richard V.J., Reimer K.A., Jennings R.B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 66:1990;913-931.
50. Paulson D.J. The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res. 34:1997;104-112.
51. + exchange in low-flow global ischemia and in ischemic preconditioning. Can J Physiol Pharmacol. 75:1997;120-127.
52. Przyklenk K., Bauer B., Ovize M., Kloner R.A., Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 87:1993;893-899.
53. Przyklenk K., Hata K., Zhao L., Kloner R.A., Elliott G.T. Disparate effects of preconditioning and MLA on 5′-NT and adenosine levels during coronary occlusion. Am J Physiol. 273:1997;H945-H951.
54. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 50:1998;413-492.
55. Ramasamy R., Liu H., Anderson S., Lundmark J., Schaefer S. Ischemic preconditioning stimulates sodium and proton transport in isolated rat hearts. J Clin Invest. 96:1995;1464-1472.
56. Rice P.J., Armstrong S.C., Ganote C.E. Concentration-response relationships for adenosine agonists during preconditioning of rabbit cardiomyocytes. J Mol Cell Cardiol. 28:1996;1355-1365.
57. Rouslin W. Regulation of the mitochondrial ATPase in situ in cardiac muscle. role of the inhibitor subunit J Bioenerg Biomembr. 23:1991;873-888.
58. + channels by protein kinase C. Circ Res. 83:1998;110-114.
59. Schultz J.J., Hsu A.K., Gross G.J. Ischemic preconditioning and morphine-induced cardioprotection involve the delta-opioid receptor in the intact rat heart. J Mol Cell Cardiol. 29:1997;2187-2195.
60. Schulz R., Rose J., Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol. 267:1994;H1341-H1352.
61. Schulz R., Post H., Vahlhaus C., Heusch G. Ischemic preconditioning in pigs. a graded phenomenon. Its relation to adenosine and bradykinin Circulation. 98:1998;1022-1029.
62. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation. 96:1997;3617-3625.
63. Skladanowski A.C., Smolenski R.T., Tavenier M., de Jong J.W., Yacoub M.H., Seymour A.-M.L. Soluble forms of 5′-nucleotidase in rat and human heart. Am J Physiol. 270:1996;H1493-H1500.
64. Soares P.R., de Albuquerque C.P., Chacko V.P., Gerstenblith G., Weiss R.G. Role of preischemic glycogen depletion in the improvement of postischemic metabolic and contractile recovery of ischemia-preconditioned rat hearts. Circulation. 96:1997;975-983.
65. Speechly-Dick M.E., Mocanu M.M., Yellon D.M. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res. 75:1994;586-590.
66. Steenbergen C., Perlman M.E., London R.E., Murphy E. Mechanism of preconditioning. Ionic alterations. Circ Res. 72:1993;112-125.
67. Takeo S., Nasa Y. Role of energy metabolism in the preconditioned heart - a possible contribution of mitochondria. Cardiovasc Res. 43:1999;32-43.
68. Vander Heide R.S., Delyani J.A., Jennings R.B., Reimer K.A., Steenbergen C. Reducing lactate accumulation does not attenuate lethal ischemic injury in isolated perfused rat hearts. Am J Physiol. 270:1996;H38-H44.
69. Van Wylen D.G.L. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation. 89:1994;2283-2289.
70. Verdouw P.D., van den Doel M.A., de Zeeuw S., Duncker D.J. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res. 39:1998;121-135.
71. Weinbrenner C., Baines C.P., Liu G.-S., Armstrong S.C., Ganote C.E., Walsh A.H., Honkanen R.E., Cohen M.V., Downey J.M. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Circulation. 98:1998;899-905.
72. Weiss R.G., de Albuquerque C.P., Vandegaer K., Chacko V.P., Gerstenblith G. Attenuated glycogenolysis reduces glycolytic catabolite accumulation during ischemia in preconditioned rat hearts. Circ Res. 79:1996;435-446.
73. Wolfe C.L., Sievers R.E., Visseren F.L.J., Donnelly T.J. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation. 87:1993;881-892.
74. Yang X.M., Sato H., Downey J.M., Cohen M.V. Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. J Mol Cell Cardiol. 29:1997;991-999.
75. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation. 89:1994;1769-1775.
76. Yellon D.M., Baxter G.F., Garcia-Dorado D., Heusch G., Sumeray M.S. Ischaemic preconditioning. present position and future directions Cardiovasc Res. 37:1998;21-33.